FDA Inspection
Alvogen, IncAlvogen, Inc – FDA Inspection, Sep 11, 2020
Record Details
This FDA Inspection record concerns Alvogen, Inc, with an inspection on September 11, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Alvogen, Inc
- Inspection Date
- September 11, 2020
- Product Type
- Drugs
View Company Profile
ID · e5b1b2ea-1f6f-41ae-ad58-83e75d7f50f0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1129003
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 314.80(c)(1)(i)Late submission of 15-day report
- 21 CFR 314.80(c)(2)Interval
- 21 CFR 314.80(b)Failure to develop written procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Alvogen, Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| November 21, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 10, 2021 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 18, 2017 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 20, 2011 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Alvogen, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.